Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
China
· Delayed Price · Currency is CNY 29.90
-1.44 (-4.59%)
Last updated: Jun 6, 2025
SHA:688443 Revenue
Chongqing Genrix Biopharmaceutical had revenue of 20.16M CNY in the quarter ending March 31, 2025, with 318,317.35% growth. This brings the company's revenue in the last twelve months to 50.24M, up 4,394.87% year-over-year. In the year 2024, Chongqing Genrix Biopharmaceutical had annual revenue of 30.09M with 2,384.11% growth.
Revenue (ttm)
50.24M
Revenue Growth
+4,394.87%
P/S Ratio
219.81
Revenue / Employee
67.62K
Employees
743
Market Cap
11.04B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |